Investor Stock List
Ranked #548 of 8,699 institutional investors

Avoro Capital Advisors LLC

New York, NY

$8.75B
US stock portfolio at live prices · today −$78.8M (−0.89%)
Live prices, last trade 11:41 AM ET
Value at quarter end (Q3 2026)
$9.69B
Change from Q2 2026
−$1.45B (−12.98%)
Positions
25 · 3 new, 0 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$1.47B of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
UTHR 17.5%ARGX 10.7%KRYS 10.4%KYMR 9.93%MDGL 8.18%
StockSharesValue, live% of portfoliovs Q2 2026
UTHR United Therapeutics Corporation2,755,555$1.53B17.5%Reduced −1%
ARGX argenx SE1,000,000$938M10.7%Unchanged
KRYS Krystal Biotech, Inc.2,888,888$908M10.4%Unchanged
KYMR Kymera Therapeutics, Inc.7,474,747$869M9.93%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.1,833,333$716M8.18%Unchanged
ARWR Arrowhead Pharmaceuticals, Inc.11,000,000$472M5.39%Reduced −3%
RVMD Revolution Medicines, Inc.2,145,000$350M4.00%Reduced −7%
CYTK Cytokinetics, Incorporated4,900,000$254M2.91%Reduced −2%
XENE Xenon Pharmaceuticals Inc.5,500,000$205M2.35%Reduced −5%
DFTX Definium Therapeutics, Inc.7,050,000$205M2.35%Reduced −2%
VERA Vera Therapeutics, Inc.5,635,000$145M1.66%Reduced −2%
GPCR Structure Therapeutics Inc.6,555,555$108M1.23%Unchanged
TSHA Taysha Gene Therapies, Inc.23,888,888$89.1M1.02%Unchanged
CELC Celcuity Inc.1,500,000$82.2M0.94%Reduced −56%
VRDN Viridian Therapeutics, Inc.2,500,000$76.9M0.88%Unchanged
COAG Hemab Therapeutics Holdings, Inc.1,892,372$74.9M0.86%Reduced −2%
OCUL Ocular Therapeutix, Inc.12,380,300$70.8M0.81%Reduced −1%
SEPN Septerna, Inc.1,300,000$50.9M0.58%Reduced −3%
ABVX ABIVAX Société Anonyme488,000$34.1M0.39%New
SCTX Scribe Therapeutics Inc.2,598,973$31.5M0.36%New
BRVE Braveheart Bio, Inc.1,255,000$25.0M0.29%New
AVTX Avalo Therapeutics, Inc.2,377,777$16.1M0.18%Added +2%
FTH Faeth Therapeutics, Inc.1,410,000$12.2M0.14%Reduced −2%
WHWK Whitehawk Therapeutics, Inc.2,849,402$8.7M<0.1%Unchanged
LXEO Lexeo Therapeutics, Inc.525,000$1.7M<0.1%Reduced −65%